Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 59

1.

Nursing interventions improve preparedness, competence, reward and burden of family caregivers in end-of-life care at home.

Anagnostou D.

Evid Based Nurs. 2019 Dec 3. pii: ebnurs-2019-103141. doi: 10.1136/ebnurs-2019-103141. [Epub ahead of print] No abstract available.

PMID:
31796498
2.

Palliative care interventions in intensive care unit patients - a systematic review protocol.

Metaxa V, Anagnostou D, Vlachos S, Arulkumaran N, van Dusseldorp I, Bensemmane S, Aslakson R, Davidson JE, Gerritsen R, Hartog C, Curtis R.

Syst Rev. 2019 Jun 22;8(1):148. doi: 10.1186/s13643-019-1064-y.

3.

Migration of Type III Secretion System Transcriptional Regulators Links Gene Expression to Secretion.

Charova SN, Gazi AD, Mylonas E, Pozidis C, Sabarit B, Anagnostou D, Psatha K, Aivaliotis M, Beuzon CR, Panopoulos NJ, Kokkinidis M.

mBio. 2018 Jul 31;9(4). pii: e01096-18. doi: 10.1128/mBio.01096-18.

4.

Symptom management, nutrition and hydration at end-of-life: a qualitative exploration of patients', carers' and health professionals' experiences and further research questions.

Baillie J, Anagnostou D, Sivell S, Van Godwin J, Byrne A, Nelson A.

BMC Palliat Care. 2018 Apr 16;17(1):60. doi: 10.1186/s12904-018-0314-4.

5.

Development of an intervention to support patients and clinicians with advanced lung cancer when considering systematic anticancer therapy: protocol for the PACT study.

Anagnostou D, Sivell S, Noble S, Lester J, Byrne A, Sampson C, Longo M, Nelson A.

BMJ Open. 2017 Jul 12;7(7):e015277. doi: 10.1136/bmjopen-2016-015277.

6.

Palliative care improves quality of life and reduces symptom burden in adults with life-limiting illness.

Anagnostou D.

Evid Based Nurs. 2017 Apr;20(2):47-48. doi: 10.1136/eb-2016-102603. Epub 2017 Mar 1. No abstract available.

PMID:
28249959
7.

Complete stent fracture 1 year after LIMA PCI due to LIMA and subclavian artery dissection.

Anagnostou D, Sanidas E, Paizis I, Barbetseas J.

Oxf Med Case Reports. 2015 Sep 1;2015(9):317-9. doi: 10.1093/omcr/omv050. eCollection 2015 Sep.

8.

Tailorable optical scattering properties of V-shaped plasmonic nanoantennas: a computationally efficient and fast analysis.

Rashidi A, Chryssomallis MT, Anagnostou DE.

J Opt Soc Am A Opt Image Sci Vis. 2014 Oct 1;31(10):2256-62. doi: 10.1364/JOSAA.31.002256.

PMID:
25401253
9.

A Churg-Strauss syndrome patient with myopericardial involvement.

Papadimitraki ED, Moyssakis I, Mavrogeni S, Mylona M, Anagnostou D, Merkouris K, Barbetseas J.

J Cardiol Cases. 2014 Nov 11;11(2):52-55. doi: 10.1016/j.jccase.2014.10.003. eCollection 2015 Feb.

10.

Elevated left ventricular filling pressures can be estimated with accuracy by a new mathematical model.

Terrovitis JV, Kapelios CJ, Sainis G, Ntalianis A, Kaldara E, Sousonis V, Vakrou S, Michelinakis N, Anagnostou D, Margari Z, Nanas JN.

J Heart Lung Transplant. 2013 May;32(5):511-7. doi: 10.1016/j.healun.2013.01.986. Epub 2013 Feb 9.

PMID:
23402945
11.

Increased expression of cyclin-D1 on trephine bone marrow biopsies independently predicts for shorter overall survival in patients with multiple myeloma treated with novel agents.

Tasidou A, Roussou M, Terpos E, Kastritis E, Gkotzamanidou M, Gavriatopoulou M, Migkou M, Eleutherakis-Papaiakovou E, Nikitas N, Anagnostou D, Dimopoulos MA.

Am J Hematol. 2012 Jul;87(7):734-6. doi: 10.1002/ajh.23223. Epub 2012 May 6.

12.

Diffuse MRI marrow pattern correlates with increased angiogenesis, advanced disease features and poor prognosis in newly diagnosed myeloma treated with novel agents.

Moulopoulos LA, Dimopoulos MA, Christoulas D, Kastritis E, Anagnostou D, Koureas A, Roussou M, Gavriatopoulou M, Migkou M, Iakovaki M, Gkotzamanidou M, Tasidou A, Terpos E.

Leukemia. 2010 Jun;24(6):1206-12. doi: 10.1038/leu.2010.70. Epub 2010 Apr 29. No abstract available.

PMID:
20428203
13.

Translocation detection in lymphoma diagnosis by split-signal FISH: a standardised approach.

van Rijk A, Mason D, Jones M, Cabeçadas J, Crespo M, Cigudosa JC, Garcia JF, Leoncini L, Cocco M, Hansmann ML, Mottok A, Copie Bergman C, Baia M, Anagnostou D, Pouliou E, Hamilton Dutoit S, Hjøllund Christiansen M, Svenstrup Poulsen T, Hauge Matthiesen S, van Dongen J, van Krieken JH.

J Hematop. 2008 Sep;1(2):119-26. doi: 10.1007/s12308-008-0017-5. Epub 2008 Aug 29.

14.

Increased expression of macrophage inflammatory protein-1alpha on trephine biopsies correlates with extensive bone disease, increased angiogenesis and advanced stage in newly diagnosed patients with multiple myeloma.

Roussou M, Tasidou A, Dimopoulos MA, Kastritis E, Migkou M, Christoulas D, Gavriatopoulou M, Zagouri F, Matsouka C, Anagnostou D, Terpos E.

Leukemia. 2009 Nov;23(11):2177-81. doi: 10.1038/leu.2009.130. Epub 2009 Jul 9. No abstract available.

PMID:
19587705
15.

Clinical characteristics and course of CD8+ cytotoxic variant of mycosis fungoides: a case series of seven patients.

Nikolaou VA, Papadavid E, Katsambas A, Stratigos AJ, Marinos L, Anagnostou D, Antoniou C.

Br J Dermatol. 2009 Oct;161(4):826-30. doi: 10.1111/j.1365-2133.2009.09301.x. Epub 2009 May 8.

PMID:
19558552
16.

TCRVb repertoire abnormalities in patients with cutaneous T-cell lymphoma.

Papadavid E, Kapsimali V, Psarra A, Antoniou C, Papasteriadi C, Ekonomidou J, Anagnostou D, Nikolaou V, Kounaki D, Dalamaga M, Bamia C, Stratigos A, Stavrianeas N, Katsambas A.

Leuk Lymphoma. 2009 Jan;50(1):130-2. doi: 10.1080/10428190802526956. No abstract available.

PMID:
19152167
17.

Non-gastric extra-nodal marginal zone lymphomas--a single centre experience on 76 patients.

Kalpadakis C, Pangalis GA, Vassilakopoulos TP, Kyrtsonis MC, Siakantaris MP, Kontopidou FN, Korkolopoulou P, Bobotsis P, Sahanas S, Tzenou T, Anagnostou D, Dimitriadou E, Yiakoumis X, Patsouris E, Roussou P, Panayiotidis P, Papadaki E, Angelopoulou MK.

Leuk Lymphoma. 2008 Dec;49(12):2308-15. doi: 10.1080/10428190802510331.

PMID:
19052978
18.

Lymphocyte subpopulation imbalances, bone marrow hematopoiesis and histopathology in rituximab-treated lymphoma patients with late-onset neutropenia.

Stamatopoulos K, Papadaki T, Pontikoglou C, Athanasiadou I, Stavroyianni N, Bux J, Batsis I, Pyrovolaki K, Paterakis G, Anagnostou D, Anagnostopoulos A, Papadaki HA.

Leukemia. 2008 Jul;22(7):1446-9. doi: 10.1038/sj.leu.2405077. Epub 2008 Jan 10. No abstract available.

PMID:
18185527
19.

A unique case of IgD-only splenic marginal-zone lymphoma with mutated immunoglobulin genes: ontogenetic implications.

Papadaki T, Stamatopoulos K, Mavrommatis T, Anagnostopoulos A, Anagnostou D.

Leuk Res. 2008 Jan;32(1):155-7. Epub 2007 Apr 8.

PMID:
17420049
20.

Splenic marginal-zone lymphoma: one or more entities? A histologic, immunohistochemical, and molecular study of 42 cases.

Papadaki T, Stamatopoulos K, Belessi C, Pouliou E, Parasi A, Douka V, Laoutaris N, Fassas A, Anagnostopoulos A, Anagnostou D.

Am J Surg Pathol. 2007 Mar;31(3):438-46.

PMID:
17325486
21.

Bone marrow histological findings in systemic lupus erythematosus with hematologic abnormalities: a clinicopathological study.

Voulgarelis M, Giannouli S, Tasidou A, Anagnostou D, Ziakas PD, Tzioufas AG.

Am J Hematol. 2006 Aug;81(8):590-7.

22.

Extranodal non-Hodgkin's lymphoma presenting as an abdominal wall mass. A case report and review of the literature.

Bozas G, Anagnostou D, Tassidou A, Moulopoulos LA, Bamias A, Dimopoulos MA.

Leuk Lymphoma. 2006 Feb;47(2):329-32.

PMID:
16321866
23.

Myelofibrosis-associated massive splenomegaly: a cause of increased intra-abdominal pressure, pulmonary hypertension, and positional dyspnea.

Ziakas PD, Voulgarelis M, Felekouras E, Anagnostou D, Tzelepis GE.

Am J Hematol. 2005 Oct;80(2):128-32.

24.

Molecular analysis of B-cell clonality in Helicobacter pylori gastritis.

Georgopoulos SD, Triantafyllou K, Fameli M, Kitsanta P, Spiliadi C, Anagnostou D, Ladas SD.

Dig Dis Sci. 2005 Sep;50(9):1616-20.

PMID:
16133959
26.

Immunoglobulin heavy- and light-chain repertoire in splenic marginal zone lymphoma.

Stamatopoulos K, Belessi C, Papadaki T, Kalagiakou E, Stavroyianni N, Douka V, Afendaki S, Saloum R, Parasi A, Anagnostou D, Laoutaris N, Fassas A, Anagnostopoulos A.

Mol Med. 2004 Jul-Dec;10(7-12):89-95.

27.

Treatment of relapsed/refractory multiple myeloma with thalidomide-based regimens: identification of prognostic factors.

Anagnostopoulos A, Gika D, Hamilos G, Zervas K, Zomas A, Pouli A, Zorzou M, Kastritis E, Anagnostopoulos N, Tassidou A, Anagnostou D, Dimopoulos MA.

Leuk Lymphoma. 2004 Nov;45(11):2275-9.

PMID:
15512817
28.

Clinical and morphological features of paediatric myelodysplastic syndromes: a review of 34 cases.

Polychronopoulou S, Panagiotou JP, Kossiva L, Mavrou A, Anagnostou D, Haidas S.

Acta Paediatr. 2004 Aug;93(8):1015-23. Review.

PMID:
15456186
29.

Primary breast lymphoma in a male patient.

Mpallas G, Simatos G, Tasidou A, Patra E, Galateros G, Lakiotis G, Papanicolaou S, Mpallas E, Anagnostou D.

Breast. 2004 Oct;13(5):436-8.

PMID:
15454203
30.

Autoimmune manifestations in common variable immunodeficiency.

Giannouli S, Anagnostou D, Soliotis F, Voulgarelis M.

Clin Rheumatol. 2004 Oct;23(5):449-52. Epub 2004 Jun 18.

PMID:
15278751
31.

An extensive traumatic degloving lesion of the penis. A case report and review of the literature.

Paraskevas KI, Anagnostou D, Bouris C.

Int Urol Nephrol. 2003;35(4):523-7. Review.

PMID:
15198161
32.

Combined therapy with rituximab plus cyclophosphamide/doxorubicin/vincristine/prednisone (CHOP) for Sjögren's syndrome-associated B-cell aggressive non-Hodgkin's lymphomas.

Voulgarelis M, Giannouli S, Anagnostou D, Tzioufas AG.

Rheumatology (Oxford). 2004 Aug;43(8):1050-3. Epub 2004 Jun 8.

PMID:
15187246
33.

Discordant response or progression in patients with myeloma treated with thalidomide-based regimens.

Anagnostopoulos A, Hamilos G, Zorzou MP, Grigoraki V, Anagnostou D, Dimopoulos MA.

Leuk Lymphoma. 2004 Jan;45(1):113-6.

PMID:
15061206
34.

Splenic marginal zone lymphomas with peripheral CD5 expression.

Giannouli S, Paterakis G, Ziakas PD, Anagnostou D, Voulgarelis M.

Haematologica. 2004 Jan;89(1):113-4. No abstract available.

35.

Myelodysplasia and Naxos disease: a novel pathogenetic association?

Polychronopoulou S, Tsatsopoulou A, Papadhimitriou SI, Panagiotou JP, Anastasakis A, Paterakis G, Anagnostou D, Protonotarious N, Haidas SA.

Leukemia. 2002 Nov;16(11):2335-7. No abstract available.

36.

Concomitant angioimmunoblastic T-cell lymphoma and low grade B-cell lymphoproliferative disorder.

Christopoulos C, Tassidou A, Golfinopoulou S, Anastasiadis G, Manetas S, Anagnostou D.

Clin Lab Haematol. 2001 Apr;23(2):139-42.

PMID:
11488855
37.

Molecular analysis of bcl-1/IgH junctional sequences in mantle cell lymphoma: potential mechanism of the t(11;14) chromosomal translocation.

Stamatopoulos K, Kosmas C, Belessi C, Kyriazopoulos P, Papadaki T, Anagnostou D, Loukopoulos D.

Br J Haematol. 1999 Apr;105(1):190-7.

PMID:
10233383
38.

Extensive apoptosis of bone marrow cells as evaluated by the in situ end-labelling (ISEL) technique may be the basis for ineffective haematopoiesis in patients with myelodysplastic syndromes.

Parcharidou A, Raza A, Economopoulos T, Papageorgiou E, Anagnostou D, Papadaki T, Raptis S.

Eur J Haematol. 1999 Jan;62(1):19-26.

PMID:
9918307
39.

Somatic hypermutation of immunoglobulin variable region genes: focus on follicular lymphoma and multiple myeloma.

Kosmas C, Stamatopoulos K, Papadaki T, Belessi C, Yataganas X, Anagnostou D, Loukopoulos D.

Immunol Rev. 1998 Apr;162:281-92. Review.

PMID:
9602371
40.
41.

Follicular lymphoma immunoglobulin kappa light chains are affected by the antigen selection process, but to a lesser degree than their partner heavy chains.

Stamatopoulos K, Kosmas C, Papadaki T, Pouliou E, Belessi C, Afendaki S, Anagnostou D, Loukopoulos D.

Br J Haematol. 1997 Jan;96(1):132-46.

PMID:
9012699
42.

Analysis of the kappa light chain variable region in multiple myeloma.

Kosmas C, Viniou NA, Stamatopoulos K, Courtenay-Luck NS, Papadaki T, Kollia P, Paterakis G, Anagnostou D, Yataganas X, Loukopoulos D.

Br J Haematol. 1996 Aug;94(2):306-17.

PMID:
8759891
43.

Secondary malignancies in a child with Hodgkin's disease: T-cell lymphoma and myelodysplastic syndrome evolving into acute nonlymphoblastic leukaemia.

Polychronopoulou S, Panagiotou JP, Papadakis T, Mavrou A, Anagnostou D, Haidas S.

Med Pediatr Oncol. 1996 May;26(5):359-66.

PMID:
8614370
44.

Primary granulocytic sarcoma of the testis.

Economopoulos T, Alexopoulos C, Anagnostou D, Stathakis N, Constantinidou M, Papageorgiou E.

Leukemia. 1994 Jan;8(1):199-200.

PMID:
8289489
45.

Epstein-Barr virus in Kikuchi-Fujimoto disease.

Anagnostopoulos I, Hummel M, Korbjuhn P, Papadaki T, Anagnostou D, Stein H.

Lancet. 1993 Apr 3;341(8849):893. No abstract available.

PMID:
8096590
46.

Detection of gene rearrangements in reactive lymphoid processes.

Orphanos V, Anagnostou D, Papadaki T, Maniatis GM, Athanassiadou A.

Leuk Lymphoma. 1993 Jan;9(1-2):103-6.

PMID:
8477189
47.

Ocular granulocytic sarcoma in childhood acute myelogenous leukemia.

Kalmanti M, Anagnostou D, Liarikos S, Pappas I, Dimitriou E, Eliopoulos G, Kalmantis T.

Acta Paediatr Jpn. 1991 Apr;33(2):172-6.

PMID:
1957641
48.

Analysis of mammosomatotropic cells in normal and neoplastic human pituitary tissues by the reverse hemolytic plaque assay and immunocytochemistry.

Lloyd RV, Anagnostou D, Cano M, Barkan AL, Chandler WF.

J Clin Endocrinol Metab. 1988 Jun;66(6):1103-10.

PMID:
3286671
49.

Dopamine receptors in immunohistochemically characterized null cell adenomas and normal human pituitaries.

Lloyd RV, Anagnostou D, Chandler WF.

Mod Pathol. 1988 Jan;1(1):51-6.

PMID:
2467283
50.

Basal-cell carcinoma of the lower lid in a 27-month-old child.

Keramidas DC, Anagnostou D.

Z Kinderchir. 1987 Aug;42(4):250-1.

PMID:
3673286

Supplemental Content

Loading ...
Support Center